Giulia Corradetti, MD, is a research scientist at Doheny Eye Institute.
ARVO 2025: Post-hoc analysis on GATHER 2 clinical trial data
Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.
Read More
Envision Summit 2025: Prediction of structural OCT biomarkers in intermediate AMD using deep learning
At the Envision Summit 2025 in San Juan, Puerto Rico, Giulia Corradetti, MD discussed AI applications in the identification and prediction of OCT structural biomarkers in intermediate AMD.